UNSPSC 51162011: Ephedrine/guaifenesin/phenobarbital/theophylline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162011 Ephedrine/guaifenesin/phenobarbital/theophylline is a Commodity code that state and local governments tag for pharmaceutical procurement, though the recent opportunities show divergence between the code's nominal scope and the work actually being bought. Seminole County, Florida issued an IFB for naloxone and safe drug deactivation systems—emergency response supplies rather than the specific combination medications the code name suggests—while Hall County, Georgia posted an RFQ/P for comprehensive on-site pharmacy services, including stocking and dispensing of 25 specified formulary medications across multiple therapeutic categories. Neither opportunity directly involves the ephedrine/guaifenesin/phenobarbital/theophylline combination. The issuing bodies are county health systems and government employee benefits administrators procuring either emergency pharmaceutical supplies or operational pharmacy management for government-employed populations and their dependents. The code shows little relevant recent activity aligned with its nominal scope; opportunities tagged to it appear to be community health systems and county government health plans using the code as a catch-all for pharmaceutical services and supplies rather than as a precise match to the formulary combination named.

Geographic activity is limited to Florida and Georgia in the available records. Seminole County's IFB (posted June 30, 2026, response deadline July 26, 2023) sought quarterly deliveries of naloxone and drug deactivation systems to its community health building in Sanford, with a two-year initial term and one-year renewal option. Hall County's RFQ/P #47-010 (posted May 4, 2026, due June 4, 2026) covers on-site pharmacy services at the Family Health Center Clinic in Gainesville for approximately 3,005 eligible individuals across co-pay, HSA, and Medicare Advantage plan populations, with an initial one-year term beginning January 1, 2027, and four optional one-year renewals. Neither solicitation specifies set-aside designations or budget ranges. Business development professionals should treat this code as showing marginal fit to pharmaceutical procurement opportunities at the state and local level; if pursuing county health system or employee benefits work, verify the actual service scope before assuming alignment with this code.